子痫
医学
阿司匹林
生物标志物
重症监护医学
怀孕
疾病
胎儿
产科
内科学
遗传学
生物化学
生物
化学
作者
Tinnakorn Chaiworapongsa,Piya Chaemsaithong,Steven J. Korzeniewski,Lami Yeo,Roberto Romero
标识
DOI:10.1038/nrneph.2014.103
摘要
Current management of pre-eclampsia consists of controlling maternal hypertension, preventing seizures and delivering the fetus at term. To aid clinical management, efforts are underway to identify biomarkers that can predict pre-eclampsia as early as the first trimester. In this second part of their Review on pre-eclampsia, Chaiworapongsa and colleagues describe these efforts, as well as the current management strategies for these patients. An antiangiogenic state might constitute a terminal pathway for the multiple aetiologies of pre-eclampsia, especially those resulting from placental abnormalities. The levels of angiogenic and antiangiogenic proteins in maternal blood change prior to a diagnosis of pre-eclampsia, correlate with disease severity and have prognostic value in identifying women who will develop maternal and/or perinatal complications. Potential interventions exist to ameliorate the imbalance of angiogenesis and, hence, might provide opportunities to improve maternal and/or perinatal outcomes in pre-eclampsia. Current strategies for managing pre-eclampsia consist of controlling hypertension, preventing seizures and timely delivery of the fetus. Prediction of pre-eclampsia in the first trimester is of great interest, as early administration of aspirin might reduce the risk of pre-eclampsia, albeit modestly. Combinations of biomarkers typically predict pre-eclampsia better than single biomarkers; however, the encouraging initial results of biomarker studies require external validation in other populations before they can be used to facilitate intervention in patients identified as at increased risk. Angiogenic and antiangiogenic factors might also be useful in triage of symptomatic patients with suspected pre-eclampsia, differentiating pre-eclampsia from exacerbations of pre-existing medical conditions and performing risk assessment in asymptomatic women. This Review article discusses the performance of predictive and prognostic biomarkers for pre-eclampsia, current strategies for preventing and managing the condition and its long-term consequences.
科研通智能强力驱动
Strongly Powered by AbleSci AI